or
forgot password

    • cancer clinical trials in massachusetts

    • Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    North Shore Medical Center Cancer Center

    Trial Locations
    North Shore Medical Center Cancer Center
    Berkshire Hematology Oncology PC
    Commonwealth Hematology Oncology PC-Quincy
    South Shore Hospital
    Baystate Medical Center
    Morton Hospital and Medical Center
    Noble Hospital
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Breast Cancer
    Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Partners Cancer Care
    South Shore Hospital
    Lung Cancer
    Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Cancer Research Center at Boston Medical Center
    Dana-Farber/Brigham and Women's Cancer Center
    Hudner Oncology Center at Saint Anne's Hospital - Fall River
    Head and Neck Cancer
    Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Melanoma (Skin)
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Caritas St. Elizabeth's Medical Center
    Leukemia
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Brain Tumor, Central Nervous System Tumor
    Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
    Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Chronic Lymphocytic Leukemia
    Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Massachusetts General Hospital Cancer Center
    Boston, Massachusetts 02114
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    Tufts-New England Medical Center, The Neeley Center for Clinical Research
    Boston, Massachusetts 02111
    Pancreatic Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Floating Hospital for Children
    Baystate Regional Cancer Program at Baystate Medical Center
    UMASS Memorial Cancer Center - University Campus
    Kidney Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Boston Medical Center

    Trial Locations
    Boston Medical Center
    Eastern Cooperative Oncology Group
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (Paradigm Trial)
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Head and Neck Cancer
    Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Head and Neck Cancer
    Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer
    Bethke Cancer Center at Emerson Hospital

    Trial Locations
    Bethke Cancer Center at Emerson Hospital
    Hudner Oncology Center at Saint Anne's Hospital - Fall River
    Lowell General Hospital
    NSMC Cancer Center - Peabody
    Chemotherapeutic Agent Toxicity, Head and Neck Cancer, Mucositis, Radiation Toxicity, Xerostomia
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Cancer Research Center at Boston Medical Center

    Trial Locations
    Cancer Research Center at Boston Medical Center
    Caritas St. Elizabeth's Medical Center
    Hudner Oncology Center at Saint Anne's Hospital
    Caritas Norwood Hospital
    NSMC Cancer Center - Peabody
    Jordan Hospital Club Cancer Center
    South Shore Hospital
    Colorectal Cancer
    Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
    Eastern Cooperative Oncology Group
    Boston, Massachusetts 02215
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Unspecified Adult Solid Tumor, Protocol Specific
    Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Head and Neck Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Boston University Cancer Research Center
    Lahey Clinic Medical Center - Burlington
    Breast Cancer